Exact Mass: 803.4948

Exact Mass Matches: 803.4948

Found 55 metabolites which its exact mass value is equals to given mass value 803.4948, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PE(16:1(9Z)/6 keto-PGF1alpha)

(2-aminoethoxy)[(2R)-2-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-3-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphinic acid

C41H74NO12P (803.4948)


PE(16:1(9Z)/6 keto-PGF1alpha) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(16:1(9Z)/6 keto-PGF1alpha), in particular, consists of one chain of one 9Z-hexadecenoyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(6 keto-PGF1alpha/16:1(9Z))

(2-aminoethoxy)[(2R)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-2-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphinic acid

C41H74NO12P (803.4948)


PE(6 keto-PGF1alpha/16:1(9Z)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(6 keto-PGF1alpha/16:1(9Z)), in particular, consists of one chain of one 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of 9Z-hexadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(16:1(9Z)/TXB2)

(2-aminoethoxy)[(2R)-2-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-3-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphinic acid

C41H74NO12P (803.4948)


PE(16:1(9Z)/TXB2) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(16:1(9Z)/TXB2), in particular, consists of one chain of one 9Z-hexadecenoyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(TXB2/16:1(9Z))

(2-aminoethoxy)[(2R)-3-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-2-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphinic acid

C41H74NO12P (803.4948)


PE(TXB2/16:1(9Z)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(TXB2/16:1(9Z)), in particular, consists of one chain of one Thromboxane B2 at the C-1 position and one chain of 9Z-hexadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PS(15:0/20:3(8Z,11Z,14Z)-2OH(5,6))

(2S)-2-amino-3-({[(2R)-2-{[(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoyl]oxy}-3-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C41H74NO12P (803.4948)


PS(15:0/20:3(8Z,11Z,14Z)-2OH(5,6)) is an oxidized phosphatidylserine (PS). Oxidized phosphatidylserines are glycerophospholipids in which a phosphorylserine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylserines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PS(15:0/20:3(8Z,11Z,14Z)-2OH(5,6)), in particular, consists of one chain of one pentadecanoyl at the C-1 position and one chain of 5,6-dihydroxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PSs can be synthesized via three different routes. In one route, the oxidized PS is synthetized de novo following the same mechanisms as for PSs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PS backbone, mainly through the action of LOX (PMID: 33329396).

   

PS(20:3(8Z,11Z,14Z)-2OH(5,6)/15:0)

(2S)-2-amino-3-({[(2R)-3-{[(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoyl]oxy}-2-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C41H74NO12P (803.4948)


PS(20:3(8Z,11Z,14Z)-2OH(5,6)/15:0) is an oxidized phosphatidylserine (PS). Oxidized phosphatidylserines are glycerophospholipids in which a phosphorylserine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylserines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PS(20:3(8Z,11Z,14Z)-2OH(5,6)/15:0), in particular, consists of one chain of one 5,6-dihydroxyeicosatrienoyl at the C-1 position and one chain of pentadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PSs can be synthesized via three different routes. In one route, the oxidized PS is synthetized de novo following the same mechanisms as for PSs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PS backbone, mainly through the action of LOX (PMID: 33329396).

   

cyclo[(2,2-dimethyl-3-hydroxy-7-octynoic acid)?Val?N-Me-Val-1?Hmpa?Pro?N-Me-Val-2?Thr]|viequeamide A

cyclo[(2,2-dimethyl-3-hydroxy-7-octynoic acid)?Val?N-Me-Val-1?Hmpa?Pro?N-Me-Val-2?Thr]|viequeamide A

C42H69N5O10 (803.5044)


   
   

PE(16:1(9Z)/TXB2)

PE(16:1(9Z)/TXB2)

C41H74NO12P (803.4948)


   

PE(TXB2/16:1(9Z))

PE(TXB2/16:1(9Z))

C41H74NO12P (803.4948)


   

PE(16:1(9Z)/6 keto-PGF1alpha)

PE(16:1(9Z)/6 keto-PGF1alpha)

C41H74NO12P (803.4948)


   

PE(6 keto-PGF1alpha/16:1(9Z))

PE(6 keto-PGF1alpha/16:1(9Z))

C41H74NO12P (803.4948)


   

PS(15:0/20:3(8Z,11Z,14Z)-2OH(5,6))

PS(15:0/20:3(8Z,11Z,14Z)-2OH(5,6))

C41H74NO12P (803.4948)


   

PS(20:3(8Z,11Z,14Z)-2OH(5,6)/15:0)

PS(20:3(8Z,11Z,14Z)-2OH(5,6)/15:0)

C41H74NO12P (803.4948)


   

cyclo[D-OaIle-Pro-N(Me)Val-DL-Thr-Unk-Val-N(Me)Val]

cyclo[D-OaIle-Pro-N(Me)Val-DL-Thr-Unk-Val-N(Me)Val]

C42H69N5O10 (803.5044)


   
   

SHexCer 23:3;2O/12:1;O

SHexCer 23:3;2O/12:1;O

C41H73NO12S (803.4853)


   

SHexCer 19:3;2O/16:1;O

SHexCer 19:3;2O/16:1;O

C41H73NO12S (803.4853)


   

SHexCer 15:2;2O/20:2;O

SHexCer 15:2;2O/20:2;O

C41H73NO12S (803.4853)


   

SHexCer 17:2;2O/18:2;O

SHexCer 17:2;2O/18:2;O

C41H73NO12S (803.4853)


   

SHexCer 17:3;2O/18:1;O

SHexCer 17:3;2O/18:1;O

C41H73NO12S (803.4853)


   

SHexCer 14:3;2O/21:1;O

SHexCer 14:3;2O/21:1;O

C41H73NO12S (803.4853)


   

SHexCer 21:3;2O/14:1;O

SHexCer 21:3;2O/14:1;O

C41H73NO12S (803.4853)


   

SHexCer 15:3;2O/20:1;O

SHexCer 15:3;2O/20:1;O

C41H73NO12S (803.4853)


   

SHexCer 20:3;2O/15:1;O

SHexCer 20:3;2O/15:1;O

C41H73NO12S (803.4853)


   

SHexCer 19:2;2O/16:2;O

SHexCer 19:2;2O/16:2;O

C41H73NO12S (803.4853)


   

SHexCer 16:3;2O/19:1;O

SHexCer 16:3;2O/19:1;O

C41H73NO12S (803.4853)


   

SHexCer 22:3;2O/13:1;O

SHexCer 22:3;2O/13:1;O

C41H73NO12S (803.4853)


   

PI-Cer 15:3;2O/20:1;O

PI-Cer 15:3;2O/20:1;O

C41H74NO12P (803.4948)


   

PI-Cer 21:3;2O/14:1;O

PI-Cer 21:3;2O/14:1;O

C41H74NO12P (803.4948)


   

PI-Cer 14:3;2O/21:1;O

PI-Cer 14:3;2O/21:1;O

C41H74NO12P (803.4948)


   

PI-Cer 17:3;2O/18:1;O

PI-Cer 17:3;2O/18:1;O

C41H74NO12P (803.4948)


   

PI-Cer 20:3;2O/15:1;O

PI-Cer 20:3;2O/15:1;O

C41H74NO12P (803.4948)


   

PI-Cer 16:3;2O/19:1;O

PI-Cer 16:3;2O/19:1;O

C41H74NO12P (803.4948)


   

PI-Cer 19:3;2O/16:1;O

PI-Cer 19:3;2O/16:1;O

C41H74NO12P (803.4948)


   

PI-Cer 19:2;2O/16:2;O

PI-Cer 19:2;2O/16:2;O

C41H74NO12P (803.4948)


   

PI-Cer 23:3;2O/12:1;O

PI-Cer 23:3;2O/12:1;O

C41H74NO12P (803.4948)


   

PI-Cer 22:3;2O/13:1;O

PI-Cer 22:3;2O/13:1;O

C41H74NO12P (803.4948)


   

PI-Cer 17:2;2O/18:2;O

PI-Cer 17:2;2O/18:2;O

C41H74NO12P (803.4948)


   

PI-Cer 15:2;2O/20:2;O

PI-Cer 15:2;2O/20:2;O

C41H74NO12P (803.4948)


   
   

OxPE 36:4+4O(1Cyc)

OxPE 36:4+4O(1Cyc)

C41H74NO12P (803.4948)


   

OxPE 36:4+4O(2Cyc)

OxPE 36:4+4O(2Cyc)

C41H74NO12P (803.4948)


   

cyclo[DL-Leu-DL-Leu-DL-Phe-DL-Val-DL-Phe-Unk]

cyclo[DL-Leu-DL-Leu-DL-Phe-DL-Val-DL-Phe-Unk]

C44H65N7O7 (803.4945)


   
   
   
   
   
   

(3s,6r,9r,12s,15r,18r,21r)-3,6-dibenzyl-9,15,18,21-tetraisopropyl-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

(3s,6r,9r,12s,15r,18r,21r)-3,6-dibenzyl-9,15,18,21-tetraisopropyl-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

C44H65N7O7 (803.4945)


   

(3s,6r,9r,12s,15r,18r,21r)-3,12-dibenzyl-15,18-bis[(2r)-butan-2-yl]-9-isopropyl-21-methyl-6-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

(3s,6r,9r,12s,15r,18r,21r)-3,12-dibenzyl-15,18-bis[(2r)-butan-2-yl]-9-isopropyl-21-methyl-6-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

C44H65N7O7 (803.4945)


   

(3r,6s,9r,12r,15r,18s,21s)-3,9-dibenzyl-18-[(1r)-1-hydroxyethyl]-6,21-diisopropyl-12,15-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17-hexol

(3r,6s,9r,12r,15r,18s,21s)-3,9-dibenzyl-18-[(1r)-1-hydroxyethyl]-6,21-diisopropyl-12,15-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17-hexol

C44H65N7O7 (803.4945)


   

(3s,9s,13s,16s,19r,24as)-19-[(2s)-butan-2-yl]-4,11-dihydroxy-6-[(1r)-1-hydroxyethyl]-3,13,16-triisopropyl-2,10,10,15-tetramethyl-9-(pent-4-yn-1-yl)-3h,6h,9h,13h,16h,19h,22h,23h,24h,24ah-pyrrolo[2,1-i]1,13-dioxa-4,7,10,16,19-pentaazacyclodocosane-1,7,14,17,20-pentone

(3s,9s,13s,16s,19r,24as)-19-[(2s)-butan-2-yl]-4,11-dihydroxy-6-[(1r)-1-hydroxyethyl]-3,13,16-triisopropyl-2,10,10,15-tetramethyl-9-(pent-4-yn-1-yl)-3h,6h,9h,13h,16h,19h,22h,23h,24h,24ah-pyrrolo[2,1-i]1,13-dioxa-4,7,10,16,19-pentaazacyclodocosane-1,7,14,17,20-pentone

C42H69N5O10 (803.5044)


   

3,12-dibenzyl-9-isopropyl-21-methyl-6-(2-methylpropyl)-15,18-bis(sec-butyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

3,12-dibenzyl-9-isopropyl-21-methyl-6-(2-methylpropyl)-15,18-bis(sec-butyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

C44H65N7O7 (803.4945)


   

3,6-dibenzyl-9,15,18,21-tetraisopropyl-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

3,6-dibenzyl-9,15,18,21-tetraisopropyl-12-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosa-1,4,7,10,13,16,19-heptaene-2,5,8,11,14,17,20-heptol

C44H65N7O7 (803.4945)